By contrast, the diagnostic accuracy of TBR/ADC was not significantly higher than that of single ADC or 18F-FET PET for gliomas with 1p/19q codeletion, MGMT promoter methylation and PTEN mutation (Figures 6D, E, I). This evidence concerns the gene MGMT and central nervous system cancer.